Second-line treatments for dyslipidemia in patients at risk of cardiovascular disease.
Kondo Y, Hamai J, Nezu U, Shigematsu E, Kamiko K, Yamazaki S, Yoshii T, Takahashi M, Takano T, Kawasaki S, Yamada M, Yamakawa T, Terauchi Y.
Kondo Y, et al. Among authors: yamazaki s.
Endocr J. 2014;61(4):343-51. doi: 10.1507/endocrj.ej13-0404. Epub 2014 Jan 22.
Endocr J. 2014.
PMID: 24452015
Free article.